NZNan Zhang

Nan Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nan Zhang has a total of 121 co-authors. Here are the top co-authors by number of shared publications:

  • Jialin Wang

    Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China

    8 shared publications
  • Boyu Liu

    Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, Shandong Province, 250117, China

    5 shared publications
  • Ruyue Liu

    Department of Social Medicine and Health Management, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China

    5 shared publications
  • Youhua Lu

    Cancer Hospital of Shandong First Medical University (Shandong Cancer Institute, Shandong Cancer Hospital) Jinan China

    5 shared publications
  • Jialin Wang

    Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China

    4 shared publications
  • Wenxuan Yan

    School of Public Health, Shandong Second Medical University, Weifang, China

    4 shared publications

Latest Publications

  • Open Access

    Implementing a medical opinion leader-led management model to promote timely treatment initiation among screen-positive patients with upper gastrointestinal cancer in rural China: a cluster randomised controlled trial protocol

    by Ruyue Liu, Chao Zheng, Liyu Wang, Nan Zhang, Qiang Sun

    Introduction: Upper gastrointestinal cancer (UGC), including oesophageal and gastric cancers, imposes a substantial health burden, particularly in China. Timely treatment after a positive screening result is critical, as treatment delays may contribute to disease progression and poorer outcomes. This study aims to evaluate the effectiveness of a management model led by medical opinion leaders (MOLs) in shortening the time to treatment initiation among screen-positive patients with UGC. Methods and analysis: This multicentre, cluster randomised controlled trial will be conducted at 16 secondary hospitals in Shandong province, China. The participating hospitals will be randomly assigned to the intervention or control group in a 1:1 ratio. Screen-positive patients aged 18–80 years whose UGC diagnosis is confirmed by endoscopy and pathological examination will be recruited. At least 372 participants will be enrolled. The intervention group will receive an MOL-led management intervention comprising WeChat-based health education and face-to-face consultations. The primary outcome is the 30-day timely treatment rate, defined as the proportion of participants who initiate treatment within 30 days after pathological diagnosis. Secondary outcomes are the cumulative treatment initiation rates within 60, 90 and 180 days. Baseline information will be collected at enrolment, and treatment status will be assessed at 30, 60, 90 and 180 days. Ethics and dissemination: The study protocol was reviewed and approved by the Science and Technology Ethics Committee of the School of Public Health, Shandong University (No. STEC-SPH-SDU-20250703). Written informed consent will be obtained from all participants. The study findings will be disseminated through publications in peer-reviewed journals, presentations at national and international academic conferences and communication with participating medical institutions and study participants. Trial registration number: ChiCTR2500109389.

  • Open Access

    Optimizing thresholds of fecal immunochemical test for colorectal cancer screening in average-risk residents

    by Yanxiu Liu, Yukun Feng, Qian Gao, Junyi Ji, Changqing Lu, Xiaofeng Zhang, Hengmin Ma, Xiaojie Sun, Nan Zhang

  • Open Access

    Differences in healthcare institution choice among elderly cancer patients: evidence from a cross-sectional study in Shandong Province, China

    by Kena Ma, Yukun Feng, Yuwang Shang, Yanxiu Liu, Jialin Wang, Nan Zhang

    People over 60 years old had higher cancer morbidity and mortality. We aimed to explore the factors associated with the choice of first treatment instituti

  • Open Access

    Financial toxicity in pediatric cancer: lived experiences and coping strategies of parents

    by Yan Liu, Pengfei Li, Qian Gao, Boyu Liu, Yuantao Qi, Weimin Guan, Nan Zhang, Youhua Lu

    Parents and other caregivers of pediatric cancer patients often experience severe financial toxicity due to prolonged treatment durations and substantial out-of-pocket expenses, compounding both physical and psychological burdens. Despite increasing recognition, a comprehensive understanding of these experiences remains limited. This study explored the lived experiences and coping strategies of parents confronting financial toxicity in the context of pediatric cancer in China. A descriptive phenomenological approach was employed to examine parents' lived experiences. Between April and May 2024, semi-structured, in-depth interviews were conducted with 20 parents of children with cancer, recruited through purposive sampling from three tertiary hospital in Shandong Province, China. All interviews were audio-recorded, transcribed verbatim, and analyzed using Giorgi's phenomenological method, assisted by NVivo 12.0. Analysis of the interview data identified four major categories encompassing twelve subcategories. Financial toxicity stemmed from diverse sources, including cancer-related factors, limited household economic resilience, societal expectations, and gaps in insurance coverage. Consequences included asset depletion, ongoing financial hardship, and restricted access to optimal care. Parents reported substantial psychological distress-such as anxiety, depression, and social isolation-and primarily employed passive and unsustainable coping strategies, including borrowing, asset liquidation, cutting essential expenditures, and informal employment. Pediatric cancer imposed a heavy financial burden that influenced treatment decisions, parental mental health, and overall family well-being. Inadequate insurance and limited social support exacerbated this burden. Targeted financial assistance and policy reforms are urgently needed to mitigate the impact and improve health outcomes for affected parents. Not applicable.


  • Open Access

    Colorectal Cancer Screening Preferences of Recipients and Providers: A Dual‐Perspective Discrete Choice Experiment

    by Weimin Guan, Nan Zhang, Zhengyang Lu, Mingjun Zhang, Yan Liu, Pengfei Li, Hang Yu, Boyu Liu, Wenxuan Yan, Guifeng Ma, et al.

    Background: The low participation rate in colorectal cancer (CRC) screening may be partly attributed to the lack of consideration for the preferences of both Recipients and Providers. This study aims to explore these preferences to inform the optimization of screening design and the improvement of implementation strategies. Methods: A discrete choice experiment (DCE) was conducted in Shandong Province to examine CRC screening preferences of Recipients and Providers. The attributes and levels of the DCE were determined using a systematic literature review and explored qualitatively. Questionnaires were generated through a partial factor design, and used a mixed logit model to analyze the data. Relative importance scores (RIS) and marginal willingness to pay were used to quantify preferences, and probability density functions were employed to predict changes in participation rates under varying attribute levels. Results: Preference data from 570 Recipients and 532 Providers were analyzed. The DCE included five attributes: screening cost (four levels), screening interval (four levels), bowel preparation (two levels), screening accuracy (three levels), and reduction in CRC‐related mortality risk (three levels). All attributes significantly influenced preferences. The RIS indicated that Recipients prioritized screening cost (42.8%), followed by interval (24.3%), mortality risk reduction (16.2%), accuracy (10.7%), and bowel preparation (6.0%), whereas Providers emphasized bowel preparation (35.4%), interval (31.7%), cost (25.1%), mortality risk reduction (6.4%), and accuracy (1.3%). Both groups showed strong support for biennial screening. Shortening the interval from 10 to 2 years increased Recipients' willingness to pay by CNY 1052.95 and Providers' expected charge by CNY 1370.84, which was also associated with higher predicted participation rates. Conclusion: Recipients and Providers differed in the degree of preference for the five CRC screening attributes, but the directions of their preferences were consistent. Therefore, screening strategies should aim to balance the perspectives of both groups. Where feasible, a biennial screening program that includes bowel preparation, minimizes costs and mortality risk, and maximizes accuracy is recommended.

  • Open Access

    The Impact of Multidisciplinary Team Meetings on the Survival of Stage IV NSCLC Patients

    by Zhengyang Lu, Nan Zhang, Qian Gao, Pengfei Li, Weimin Guan, Shihong Lin, Wenxuan Yan, Boyu Liu, Youhua Lu, Jinming Yu

    Background: With treatment strategies for cancer constantly evolving, the multidisciplinary team (MDT) plays a key role in optimizing cancer care, but its real‐world impact on survival remains unclear. This study aims to examine the impact of MDT on overall survival (OS) among patients with stage IV non‐small cell lung cancer (NSCLC), based on real‐world data including all eligible patients. Method: Patients with stage IV NSCLC who were admitted for the first time to Shandong Cancer Hospital from January 1, 2021 to December 31, 2021 were divided into MDT group and non‐MDT group according to MDT meeting involvement. Follow‐up period extended from January 1, 2021, to May 31, 2024. Kaplan–Meier curves and log‐rank tests were used to analyze survival differences, while Cox proportional hazards models were employed to identify factors associated with overall survival. Result: One thousand six hundred and sixty‐four patients were included. No statistical differences were found between the MDT group ( n = 1238) and the Non‐MDT group ( n = 426) in baseline characteristics, but differences were observed in treatment modalities. The MDT group exhibited a longer median overall survival compared to the Non‐MDT group (26.25 vs. 21.42 months; log‐rank χ 2 = 4.93, p = 0.03). Furthermore, MDT was associated with a reduction in the risk of mortality (adjusted HR = 0.86; 95% CI, 0.75–0.99; p < 0.05). Conclusion: MDT can effectively reduce mortality risk. Future implementation requires recognizing its potential additional benefits and developing tailored strategies.


  • Open Access

    Cost-utility of endoscopic screening strategies for upper gastrointestinal cancer across China: a modeling study

    by Ruyue Liu, Yifan Li, Xinyi Wang, Yuwang Shang, Nan Zhang, Qiang Sun

    Introduction: Endoscopic screening for upper gastrointestinal cancer (UGC) is effective, but it's cost-utility across comprehensive strategies remains unclear. We aimed to assess the cost-utility of various endoscopic screening strategies for UGC within the Chinese health care system.Methods: This study assessed the cost-utility of 40 endoscopic screening strategies using a Markov model. Strategies varied by starting ages (40, 45, 50, or 55 years), screening frequencies (once per lifetime, every 1, 2, 5, 10, or 15 years), and follow-up options. Model parameters were estimated based on our survey data, public surveillance data and published literature. The primary outcome was the incremental cost-utility ratios (ICUR). Deterministic and probabilistic sensitivity analyses were performed to examine key parameters uncertainty.Results: Seven strategies were identified as the dominant strategies given one-time per capita GDP (¥70,653) of Shandong province in China in 2019. Compared with no screening, all dominant strategies were associated with improved ICUR by CNY ¥12 095.60–31 456.29 per quality-adjusted life years (QALY). Compared with the neighboring strategy, all dominant strategies were associated with improved ICUR by CNY ¥12 095.6266 764.06 per QALY. The y40-nf-il would be the most cost-utility strategy, with probabilities of 42%−95% at 1–3 times the per capita GDP. Findings were robust in all sensitivity analysis.Conclusions: Comprehensive endoscopic screening strategies for UGC are cost-effective within the Chinese healthcare system. Annual screening starting at age 40 without follow-up emerges as the optimal approach, offering valuable evidence to guide policy development for UGC prevention and control in China.


  • Open Access

    Effect of Socioeconomic Status on Financial Toxicity: The Chain Mediating Roles of Social Support and Self‐Efficacy

    by Yan Liu, Pengfei Li, Boyu Liu, Yuantao Qi, Weimin Guan, Nan Zhang, Youhua Lu

    Objective: Cancer patients experience severe financial toxicity, with the mechanisms influencing the relationship between socioeconomic status and financial toxicity in lung cancer patients remaining poorly defined. This study aims to investigate how social support and self‐efficacy mediate the association between socioeconomic status and financial toxicity among lung cancer patients in China. Methods: A survey of 755 lung cancer patients was conducted at a tertiary oncology hospital in Shandong Province, China, from October to December 2023, utilizing random sampling. Data collection included demographic and socioeconomic details, along with assessments of social support, self‐efficacy, and financial toxicity. Regression and Bootstrap analyses were used to explore the sequential mediating effects of socioeconomic status, self‐efficacy, social support, and financial toxicity. Results: (1) Significant correlations emerged among socioeconomic status, social support, self‐efficacy, and financial toxicity ( p < 0.05). (2) Socioeconomic status was significantly associated with financial toxicity ( p < 0.05). (3) Self‐efficacy mediated the relationship between socioeconomic status and financial toxicity ( β = 0.203, p < 0.05), whereas social support did not exhibit a mediating effect in this relationship ( β = 0.039, p = 0.194). (4) Social support and self‐efficacy had a chain‐mediated role in the relationship between socioeconomic status and financial toxicity in patients with multimorbidity ( β = 0.072, p < 0.05). Conclusion: This study identifies social support and self‐efficacy as chained mediators that link socioeconomic status with financial toxicity among lung cancer patients. It is recommended that targeted interventions be implemented to increase social support for patients with lower socioeconomic status to mitigate financial toxicity.


  • Open Access

    Development of A Caregiver‐Reported Scale for Pediatric Cancer Financial Toxicity (CRS‐PCFT)

    by Pengfei Li, Nan Zhang, Xinyue Xu, Yan Liu, Zhengyang Lu, Qian Gao, Shihong Lin, Weimin Guan, Wenxuan Yan, Boyu Liu, et al.

    Background: Financial toxicity is common among families of pediatric patients with cancer. However, the availability of survey and/or screening instruments specific to pediatric family financial toxicity is limited.Methods: A two‐round cross‐sectional survey was conducted in Shandong Province, China. We combined classical test theory (CTT) and item response theory (IRT) to validate items of the caregiver‐reported scale for pediatric cancer financial toxicity (CRS‐PCFT) after Delphi. The scale structure, reliability, and validity were determined and validated by exploratory factor analysis (EFA) and confirmatory factor analysis (CFA). The threshold was discussed based on the correlations between CRS‐PCFT and socio‐factors.Findings: A 16‐item initial scale was determined after Delphi. The data from 206 pilot survey samples was used to select and validate items, and a 10‐item CRS‐PCFT was developed. The scale showed satisfactory reliability and validity based on data from 398 formal survey samples. When the CRS‐PCFT scores were into high and low toxicity groups by the median, they were significantly correlated with education (r = −0.284, p < 0.0001), household income (r = −0.253, p < 0.0001), work status (r = −0.173, p = 0.001), and cancer stages (r = 0.147, p = 0.003).Interpretation: CRS‐PCFT demonstrates robust reliability and validity and makes it more accurate to obtain the pediatric cancer financial toxicity conditions. Additional research should be done to validate CRS‐PCFT.